Severe diarrhea associated with x-linked lissencephaly with absent corpus callosum and abnormal genitalia: A case report of successful treatment with the somatostatin analogue octreotide

No To Hattatsu

Volumn 39, Issue 5, 2007, Pages 379-382

  Nanba, Yukiko ^a   Oka, Akira ^a   Ohno, Kousaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

AGYRIA; ARTICLE; CASE REPORT; CORPUS CALLOSUM; DIARRHEA; FANCONI RENOTUBULAR SYNDROME; GENITAL MALFORMATION; HUMAN; HYPERALDOSTERONISM; HYPERINSULINEMIA; HYPOGLYCEMIA; INTESTINE; INTRACTABLE EPILEPSY; KIDNEY TUBULE; LACTOSE INTOLERANCE; MALE; PRESCHOOL CHILD; VERNER MORRISON SYNDROME; X CHROMOSOME LINKED DISORDER;

ABNORMALITIES, MULTIPLE; CHILD, PRESCHOOL; CORPUS CALLOSUM; DIARRHEA; GASTROINTESTINAL AGENTS; GENES, X-LINKED; GENITALIA, MALE; HUMANS; LACTOSE INTOLERANCE; LINKAGE (GENETICS); MALE; OCTREOTIDE;

EID: 34548859235     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dobyns WB, Berry-Kravis E, Havernick NJ, Holden KB, Viskochil D. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Am J Med Genet 1999;86:331-7.
2. Kitamura K, Yanazawa M, Sugiyama N, et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 2002;32:359-69.
3. Kato M, Das S, Petras K, et al. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat 2004;23 147-59.
4. Farthing MJ. Novel targets for the control of secretory diarrhoea. Gut 2002;50:15-8.
5. Gaginella TS, O' Dorisio TM, Fassler JE, Mekhjian HS. Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin. Metabolism 1990;39(9 suppl 2):172-5.
6. Japanese source
7. Behrman RE, Kliegman RM, Jenson Hb, eds. Nelson textbook of pediatrics. 17th ed. Philadelphia: WB Saunders, 2003.
8. Japanese source
9. Collombat P, Mansouri A, Hecksher-Sorensen J, et al. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 2003;17:2591-603.
10. Hahn A, Gross C, Uyanik G, et al. X-linked lissencephaly with abnormal genitalia associated with renal phosphate wasting. Neuropediatrics 2004;35:202-5.
11. Japanese source
12. Japanese source
13. Japanese source
14. DeGroot LJ. Endocrinology. 4th ed. Philadelphia: Saunders, 2001;2547-58.
15. Heikenen JB, Pohl JF, Werlin SL, Bucuvalas JC. Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr 2002;35:600-9.
16. Tauber MT, Harris AG, Rochiccioli P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 1994;153:304-10.
17. Anthone GJ, Bastidas JA, Orandle MS, Yeo CJ. Direct proabsorptive effect of octreotide on ionic transport in the small intestine. Surgery 1990;108:1136-42.
18. Milosevic V, Velkovski S, Brkic B, et al. Inhibitory effects of centrally administered somatostatin on the adrenal zona glomerulosa in male rats. Pharmacology 1996;53:369-75.
19. Japanese source